Ingalipt-zdorovya
Ukraine
Table of Contents
INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT INGALIPT-ZDOROV'YA (INGALIPT-ZDOROVYE)
Composition:
Active substances:
1 can contains 0.75 g of soluble streptocide, 0.54 g of sulfathiazole sodium calculated as anhydrous sulfathiazole sodium, 0.015 g of thymol, 0.015 g of eucalyptus oil, 0.015 g of peppermint oil;
Excipients: ethanol 96%, refined sugar, glycerol, polysorbate-80, purified water.
Pharmaceutical form. Oral spray.
Main physicochemical properties: clear liquid, light yellow to dark yellow in color, with a characteristic odor.
Pharmacotherapeutic group. Agents acting on the respiratory system. Preparations used in throat diseases. Antiseptics. ATC code R02A A20.
Pharmacological properties.
Pharmacodynamics. The pharmacological effects of the drug are due to the action of its constituent components. Soluble streptocide and sodium sulfathiazole exert antimicrobial activity against gram-positive and gram-negative bacteria causing diseases of the oral cavity and pharynx. Thymol has antiseptic, expectorant, and spasmolytic effects. Eucalyptus oil possesses anti-inflammatory and antiseptic activity. Peppermint oil exerts a moderate local anesthetic effect when applied to mucous membranes.
The combination of these components provides comprehensive pathogenetic therapy for inflammatory diseases of the mucous membranes of the oral cavity and upper respiratory tract. The drug exerts anti-inflammatory, antimicrobial, and antifungal effects; it is active against gram-positive and gram-negative bacteria, as well as Candida species.
Clinical characteristics.
Indications. Local treatment of infectious-inflammatory diseases of the ENT organs and the oral mucosa (tonsillitis, pharyngitis, laryngitis, aphthous and ulcerative stomatitis).
Contraindications. Hypersensitivity to the components of the drug, history of severe toxic-allergic reactions to sulfonamides.
Interaction with other medicinal products and other types of interactions. If you are taking any other medicinal products, be sure to consult your doctor regarding the possibility of using this drug!
Possible reduction of the antimicrobial effect of the drug when used simultaneously with derivatives of para-aminobenzoic acid (novocaine, anesthesin, dicaine).
Special precautions.
Before using the medication, especially if you are prone to allergies, consult your doctor! Do not use the medication for longer than the recommended duration without medical advice!
Always inform your doctor about any previous reactions you have had to medications of this class.
Contact of the medication with the eyes must be avoided.
Prior to application, it is recommended to rinse the oral cavity with warm boiled water. Remove necrotic deposits from affected areas of the oral cavity (ulcers, erosions) using sterile swabs. After spraying the medication into the oral cavity, refrain from eating or drinking for 15–30 minutes.
When using the medication in children, note that a single dose sprayed over 1–2 seconds contains 0.0076–0.0152 mL of ethanol (96%), which corresponds to a single dose of: 0.0004–0.0013 mL/kg for children aged 3–5 years (body weight 15–21 kg) and 0.0002–0.0007 mL/kg for children aged 6–12 years (body weight 21–38 kg).
The medication contains sugar, which should be taken into account in patients with diabetes mellitus and in individuals with hereditary fructose intolerance or glucose-galactose malabsorption syndrome.
Use during pregnancy or breastfeeding. The use of the medication during pregnancy or breastfeeding is possible only under medical supervision, after careful assessment of the benefit-risk ratio, and with strict adherence to the prescribed dosing regimen.
Ability to affect reaction rate when driving or operating machinery. The medication does not impair the ability to drive or operate machinery. However, drivers should be aware that the medication may interfere with breathalyzer tests for alcohol.
Method of Administration and Dosage
For local application to the mucous membranes of the oral cavity and nasopharynx by spraying, adults and children aged 3 years and older should spray the medication into the oral cavity for 1–2 seconds.
Adults: spray 3–4 times daily.
Children aged 3 years and older: spray 1–2 times daily, unless otherwise directed by a physician.
The duration of treatment depends on the course of the disease and usually lasts 3–10 days.
The frequency and duration of use should be individually determined by a physician depending on the severity of the condition!
Prior to use, rinse the oral cavity with boiled water.
Instructions for Using the Canister.
- Remove the protective cap from the canister.
- Attach the provided spray nozzle to the valve stem of the canister, ensuring beforehand that it is clean.
- Shake the canister for 1 minute and perform no more than 5 actuations of the nozzle until a fine spray is produced. If no spray appears, the procedure may be repeated once.
- Insert the free end of the spray nozzle into the oral cavity and, holding the canister in an upright position, press the nozzle head. Spray for 1–2 seconds. Hold the sprayed medication in the oral cavity for 5–7 minutes without consuming food or water.
- After completing the spraying, remove the nozzle from the valve stem and cover the canister with the protective cap to prevent contamination.
- The spray nozzle should be kept clean and washed daily under warm running water, then dried thoroughly in a warm place.
Children. The medication is contraindicated in children under 3 years of age.
Use with caution in children aged 3 years and older due to the potential risk of reflex bronchospasm caused by the presence of eucalyptus and peppermint essential oils. Treatment of children should be conducted under medical supervision.
Overdose. Cases of overdose have not been reported. However, adverse effects of the medication may be intensified.
Treatment: discontinue the medication, rinse the oral cavity with warm boiled water, and provide symptomatic therapy.
Side effects.
In individual cases, the following may occur:
Immune system: allergic reactions, including angioneurotic edema, bronchospasm.
Skin: rashes, itching, urticaria, swelling at the site of contact.
Gastrointestinal system: nausea, vomiting, local effects (burning sensation in the mouth, lump in the throat or irritation, hyperemia of the pharyngeal mucosa).
Other: general weakness, difficulty breathing.
If any adverse events or unusual reactions occur, consult your doctor regarding further use of the medication.
Shelf life. 1.5 years.
Storage conditions. Store in the original packaging at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging. 1 bottle of 30 ml with spray nozzle and protective cap in a box.
Category of release. Over-the-counter (without prescription).
Manufacturer. LIMITED LIABILITY COMPANY "CORPORATION "ZDOROV'YA".
Manufacturer's address and place of business. Ukraine, 61013, Kharkiv region, city of Kharkiv, Shevchenko Street, building 22.